Anti-Candida albicans effect of the protein-carbohydrate fraction obtained from the coelomic fluid of earthworm Dendrobaena veneta

PLoS One. 2019 Mar 11;14(3):e0212869. doi: 10.1371/journal.pone.0212869. eCollection 2019.

Abstract

An antifungal active fraction (AAF) from the coelomic fluid (CF) of the earthworm Dendrobaena veneta was isolated. The aim of the study was to analyze the antifungal activity of the AAF and to carry out chemical characterization of the fraction. The active fraction showed antifungal activity against a clinical C. albicans isolate, C. albicans ATCC 10231, and C. krusei ATCC 6258. It effectively reduced the metabolic activity of C. albicans cells and influenced their morphology after 48 hours of incubation. Scanning electron microscopy (SEM) images revealed loss of integrity of the cell wall induced by the active fraction. Calcofluor White staining showed changes in the structure of the C. albicans cell wall induced by the AAF. The fungal cells died via apoptosis and necrosis after the treatment with the studied fraction. Electrophoresis under native conditions revealed the presence of two compounds in the AAF, while SDS/PAGE gel electrophoresis showed several protein and carbohydrate compounds. The active fraction was analyzed using Raman spectroscopy, MALDI TOF/TOF, and ESI LC-MS. The Raman analysis confirmed the presence of proteins and determined their secondary structure. The MALDI TOF/TOF analysis facilitated detection of four main compounds with a mass of 7694.9 m/z, 12292.3 m/z, 21628.3 m/z, and 42923.2 m/z in the analyzed fraction. The presence of carbohydrate compounds in the preparation was confirmed by nuclear magnetic resonance (NMR) and gas chromatography (GC-MS). The ATR-FTIR spectrum of the AAF exhibited high similarity to the spectrum of egg white lysozyme. The AAF showed no endotoxicity and cytotoxicity towards normal skin fibroblasts (HSF); therefore, it can be used for the treatment of skin and mucous membrane candidiasis in the future. Given its efficient and selective action, the fraction seems to be a promising preparation with antifungal activity against C. albicans.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antifungal Agents / isolation & purification
  • Antifungal Agents / pharmacology*
  • Apoptosis / drug effects
  • Candida albicans / drug effects*
  • Candidiasis / drug therapy
  • Candidiasis / microbiology
  • Cell Wall / drug effects
  • Cytotoxins / isolation & purification
  • Cytotoxins / pharmacology*
  • Drug Evaluation, Preclinical
  • Fibroblasts
  • Humans
  • Microbial Sensitivity Tests
  • Oligochaeta / chemistry*
  • Primary Cell Culture
  • Skin / cytology
  • Toxicity Tests

Substances

  • Antifungal Agents
  • Cytotoxins

Grants and funding

This work was supported by the MINIATURA 1 Project NR 2017/01/X/NZ4/00748 of the Polish National Science Center.